pp-004 Injection
Dossier type
CTD
Dossier status
Under development
Country of origin
South Korea
GMP approvals
South Korea
Comments
Recombinant Herpes Zoster Vaccine with improved immunogenicity, safety & productivity. Status: Phase 1 completed, preparing to enter Phase 2 clinical trials. Approval planned by 2030 (KR/RoW).
Manufacturer #38269
Korean clinical-stage biopharmaceutical company developing proprietary adjuvant platform technologies for infectious diseases and cancer